| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 4652-64-6 | Gly-Leu-Met-NH2 |
| | 询价 |
| 2 | 100930-11-8 | [D-Trp2,7,9] Substance P |
| | 询价 |
| 3 | 143675-79-0 | G-Protein antagonist peptide |
| | 询价 |
| 4 | 109212-72-8 | (D-Pro2,D-Trp6,8,Nle10)-Neurokinin B |
| | 询价 |
| 5 | 115760-58-2 | (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P |
| | 询价 |
| 6 | 278603-08-0 | NH125 |
| 5mg, 25mg, 100mg | 询价 |
| 7 | 89430-34-2 | [D-Pro4,D-Trp7,9,Nle11] Substance P(4-11) |
| | 询价 |
| 8 | 77128-75-7 | [Sar9] Substance P |
| | 询价 |
| 9 | 84676-91-5 | (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P |
| | 询价 |
| 10 | 77128-78-0 | [Glp5,Sar9] Substance P(5-11) |
| | 询价 |
| 11 | 32677-01-3 | H-Glu(OtBu)-OtBu hydrochloride |
| | 询价 |
| 12 | 61123-13-5 | [Glp6] Substance P(6-11) |
| | 询价 |
| 13 | 57462-42-7 | [Nle11]-Substance P |
| | 询价 |
| 14 | | [Sar4] Substance P(4-11) |
| | 询价 |
| 15 | 80434-86-2 | [D-Pro2,D-Trp7,9] Substance P |
| | 询价 |
| 16 | 56104-22-4 | [Glp5] Substance P(5-11) |
| | 询价 |
| 17 | 81381-50-2 | [DAla4] Substance P(4-11) |
| | 询价 |
| 18 | | [D-Trp7,9,10]-Substance P TFA |
| | 询价 |
| 19 | 225526-17-0 | Substance P Receptor Antagonist 1 |
| | 询价 |
| 20 | 51165-05-0 | Substance P(7-11) |
| | 询价 |
| 21 | | Substance P(1-7)TFA |
| | 询价 |
| 22 | 57468-17-4 | Substance P(1-9) |
| | 询价 |
| 23 | 68060-49-1 | Substance P(1-7) |
| | 询价 |
| 24 | 123148-51-6 | Substance P-Gly-Lys-Arg |
| | 询价 |
| 25 | 51165-07-2 | Substance P(6-11) |
| | 询价 |
| 26 | 53749-60-3 | Substance P(4-11) |
| | 询价 |
| 27 | 135306-85-3 | MEN 10376 |
| | 询价 |
| 28 | 849479-74-9 | Vapreotide acetate |
| | 询价 |
| 29 | 97559-35-8 | Neurokinin A(4-10) |
| | 询价 |
| 30 | 1375752-77-4 | (S,S)-BMS-984923 |
| | 询价 |
| 31 | 731006-86-3 | VU0155094 |
| | 询价 |
| 32 | 1310012-12-4 | VU0360172 |
| | 询价 |
| 33 | 169209-66-9 | MTPG |
| | 询价 |
| 34 | 198419-90-8 | (±)-LY367385 |
| 1mg | 询价 |
| 35 | 23052-80-4 | L-AP3 |
| | 询价 |
| 36 | 196928-50-4 | XAP044 |
| | 询价 |
| 37 | 169209-65-8 | MPPG |
| | 询价 |
| 38 | 1403783-31-2 | Nexturastat A |
| 5mg, 10mg | 询价 |
| 39 | 23327-57-3 | Nefopam hydrochloride |
| 200mg | 询价 |
| 40 | 157381-42-5 | MAP4 |
| | 询价 |
| 41 | 334887-43-3 | HexylHIBO |
| | 询价 |
| 42 | 1224431-15-5 | MFZ 10-7 |
| | 询价 |
| 43 | 6266-99-5 | (E/Z)-SIB-1893 |
| | 询价 |
| 44 | 15332-10-2 | 3,3'-Difluorobenzaldazine |
| | 询价 |
| 45 | 1314140-00-5 | TC-N 22A |
| | 询价 |
| 46 | 194918-76-8 | rel-ACPT-I |
| | 询价 |
| 47 | 78739-01-2 | D-AP4 |
| | 询价 |
| 48 | | Agouti-related Protein(AGRP)(83-132)Amide(human) |
| | 询价 |
| 49 | 944111-22-2 | PG106 |
| | 询价 |
| 50 | 357-08-4 | Naloxone hydrochloride |
| 10mg, 50mg, 100mg | 询价 |
| 51 | | PG-931 TFA |
| | 询价 |
| 52 | 475468-09-8 | (R,R)-Glycopyrrolate |
| | 询价 |
| 53 | 28797-61-7 | Pirenzepine |
| | 询价 |
| 54 | 620-61-1 | L-Hyoscyamine sulfate |
| | 询价 |
| 55 | 133099-04-4 | Darifenacin |
| 5mg | 询价 |
| 56 | 133033-93-9 | (±)-Darifenacin |
| | 询价 |
| 57 | 1189888-77-4 | N-Desmethylclozapine-d8 |
| | 询价 |
| 58 | 107233-08-9 | Cevimeline |
| | 询价 |
| 59 | | (-)-Cevimeline hydrochloride hemihydrate |
| | 询价 |
| 60 | | (+)-Cevimeline hydrochloride hemihydrate |
| | 询价 |
m.cnreagent.com